Clinical Trials

Showing trials with last updates posted in 2026.

NCT02954874 | ACTIVE_NOT_RECRUITING | PHASE3
1195 participants

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2017-01-18
Completion:
2026-08-03
Conditions
  • Breast Carcinoma In Situ
  • Invasive Breast Carcinoma
  • Stage I Breast Cancer AJCC v7
  • Stage II Breast Cancer AJCC v6 and v7
  • Stage III Breast Cancer AJCC v7
  • Triple-Negative Breast Carcinoma
Interventions
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
  • RADIATION
No Results Yet
NCT02476838 | WITHDRAWN | NA
0 participants

Hand Transplantation

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2015-06-02
Completion:
2029-01-01
Conditions
  • Amputation
Interventions
  • PROCEDURE
No Results Yet
NCT02107105 | RECRUITING
430 participants

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-31
Start Date:
2014-05-16
Completion:
2030-05-31
Conditions
  • Rectal Adenocarcinoma
  • Stage I Rectal Cancer AJCC v8
  • Stage II Rectal Cancer AJCC v8
  • Stage IIA Rectal Cancer AJCC v8
  • Stage IIB Rectal Cancer AJCC v8
  • Stage IIC Rectal Cancer AJCC v8
  • Stage III Rectal Cancer AJCC v8
  • Stage IIIA Rectal Cancer AJCC v8
  • Stage IIIB Rectal Cancer AJCC v8
  • Stage IIIC Rectal Cancer AJCC v8
  • Stage IV Rectal Cancer AJCC v8
  • Stage IVA Rectal Cancer AJCC v8
  • Stage IVB Rectal Cancer AJCC v8
  • Stage IVC Rectal Cancer AJCC v8
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page